Ann: Investor Presentation, page-8

To me the really important point in the whole preso was Tom highlighting something that has always been obvious but I don't think has every been properly articulated before. That is if they cant get a single pivotal study that will please both the US and EU, they will push on with the EU Phase III and then swing back to the US at a later date. In the worst case they have more than enough cash to see them through to the readout and possible approval of Presendin in the EU. That outcome alone will make unlock more than enough value to make us all very happy, I think when the market wants to wake up to the fact that we will be in a Phase III trial within less than 12 months and that we are fully funded then we should start to feel the love that we deserve.